A stroke of bad luck? Exploring the Stroke Drug Bottleneck

This is the extended version of an episode which aired live on the ABC Radio National Health Report. https://www.abc.net.au/listen/programs/healthreport/improving-stroke-research/11515796 SummaryThis conversation explores the personal experience of a stroke survivor, the complexities of stroke treatment, the challenges in biomedical research, and the ethical considerations surrounding animal testing. It highlights the need for improved research methodologies and the importance of recovery in the journey after a stroke.Guests:Adrian O'MalleyStroke patientProfessor David HowellsProfessor of Neuroscience and Brain Plasticity, University of TasmaniaDr Alexandra Bannach-BrownResearch Fellow, Bond UniversityConsultant in Laboratory Animal Care and ManagementReporter:Dr Lila Landowski. This episode was generated as part of Dr Lila Landowski's ABC Top 5 Scientist Media Residency.Host:James BullenProducer:Joel Werner, Carl Smith, Diane DeanTakeawaysCoordination issues can signal a stroke emergency.Stroke can lead to lifelong disabilities without proper treatment.TPA is the only drug for ischemic strokes but has strict eligibility criteria.70% of patients may not benefit from TPA even if administered.Research waste in biomedical science is a significant issue.Improving drug testing methods can lead to better stroke treatments.Animal models of stroke need to be more representative of human conditions.The three R's of animal testing are replacement, reduction, and refinement.Quality research foundations are crucial for effective treatment development.Recovery from stroke is a collaborative effort involving family support.Chapters00:00 The Day That Changed Everything02:45 Understanding Stroke and Its Impact05:54 The Quest for Better Stroke Treatments08:55 Improving Research Models for Stroke10:22 The Importance of Collaboration in RecoveryKeywords: stroke, treatment, research, biomedical science, recovery, TPA, animal testing, research waste, neuroscience, health